Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis

Mike J. Loeffelholz, Curt J. Thompson, Karla S. Long, Mary J R Gilchrist

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

We prospectively compared the performance of culture, direct fluorescent-antibody testing (DFA), and an in-house-developed PCR test targeting the repeated insertion sequence IS481 for the detection of Bordetella pertussis in nasopharyngeal swab specimens. We tested 319 consecutive paired specimens on which all three tests were performed. A total of 59 specimens were positive by one or more tests. Of these, 5 were positive by all three tests, 2 were positive by culture and PCR, 16 were positive by PCR and DFA, 28 were positive by PCR only, and 8 were positive by DFA only. Any specimen positive by culture was considered to be a true positive, as were specimens positive by both PCR and DFA. Specimens positive only by PCR or DFA were considered discrepant, and their status was resolved by review of patient histories. Patients with symptoms meeting the Centers for Disease Control and Prevention clinical case definition for pertussis and who had a specimen positive by PCR or DFA were considered to have true B. pertussis infections. Of the 28 patients positive by PCR only, 20 met the clinical case definition for pertussis, while 3 of the 8 patients positive by DFA only met the clinical case definition. After resolution of the status of discrepant specimens, the sensitivity, specificity, positive predictive value, and negative predictive value were 15.2, 100, 100, and 87.5%, respectively, for culture; 93.5, 97.1, 84.3, and 98.9%, respectively, for PCR; and 52.2, 98.2, 82.8, and 92.4%, respectively, for DFA. The actual positive predictive value of PCR was probably greater, as several PCR-positive patients who did not meet the clinical case definition had symptoms consistent with typical or atypical pertussis. PCR is a sensitive and specific method for the detection of B. pertussis.

Original languageEnglish (US)
Pages (from-to)2872-2876
Number of pages5
JournalJournal of Clinical Microbiology
Volume37
Issue number9
StatePublished - 1999
Externally publishedYes

Fingerprint

Bordetella pertussis
Polymerase Chain Reaction
Antibodies
Whooping Cough
Bordetella Infections
Insertional Mutagenesis
Centers for Disease Control and Prevention (U.S.)

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Loeffelholz, M. J., Thompson, C. J., Long, K. S., & Gilchrist, M. J. R. (1999). Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis. Journal of Clinical Microbiology, 37(9), 2872-2876.

Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis. / Loeffelholz, Mike J.; Thompson, Curt J.; Long, Karla S.; Gilchrist, Mary J R.

In: Journal of Clinical Microbiology, Vol. 37, No. 9, 1999, p. 2872-2876.

Research output: Contribution to journalArticle

Loeffelholz, MJ, Thompson, CJ, Long, KS & Gilchrist, MJR 1999, 'Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis', Journal of Clinical Microbiology, vol. 37, no. 9, pp. 2872-2876.
Loeffelholz, Mike J. ; Thompson, Curt J. ; Long, Karla S. ; Gilchrist, Mary J R. / Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis. In: Journal of Clinical Microbiology. 1999 ; Vol. 37, No. 9. pp. 2872-2876.
@article{578869936e8f4c31b0149066b4800a22,
title = "Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis",
abstract = "We prospectively compared the performance of culture, direct fluorescent-antibody testing (DFA), and an in-house-developed PCR test targeting the repeated insertion sequence IS481 for the detection of Bordetella pertussis in nasopharyngeal swab specimens. We tested 319 consecutive paired specimens on which all three tests were performed. A total of 59 specimens were positive by one or more tests. Of these, 5 were positive by all three tests, 2 were positive by culture and PCR, 16 were positive by PCR and DFA, 28 were positive by PCR only, and 8 were positive by DFA only. Any specimen positive by culture was considered to be a true positive, as were specimens positive by both PCR and DFA. Specimens positive only by PCR or DFA were considered discrepant, and their status was resolved by review of patient histories. Patients with symptoms meeting the Centers for Disease Control and Prevention clinical case definition for pertussis and who had a specimen positive by PCR or DFA were considered to have true B. pertussis infections. Of the 28 patients positive by PCR only, 20 met the clinical case definition for pertussis, while 3 of the 8 patients positive by DFA only met the clinical case definition. After resolution of the status of discrepant specimens, the sensitivity, specificity, positive predictive value, and negative predictive value were 15.2, 100, 100, and 87.5{\%}, respectively, for culture; 93.5, 97.1, 84.3, and 98.9{\%}, respectively, for PCR; and 52.2, 98.2, 82.8, and 92.4{\%}, respectively, for DFA. The actual positive predictive value of PCR was probably greater, as several PCR-positive patients who did not meet the clinical case definition had symptoms consistent with typical or atypical pertussis. PCR is a sensitive and specific method for the detection of B. pertussis.",
author = "Loeffelholz, {Mike J.} and Thompson, {Curt J.} and Long, {Karla S.} and Gilchrist, {Mary J R}",
year = "1999",
language = "English (US)",
volume = "37",
pages = "2872--2876",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis

AU - Loeffelholz, Mike J.

AU - Thompson, Curt J.

AU - Long, Karla S.

AU - Gilchrist, Mary J R

PY - 1999

Y1 - 1999

N2 - We prospectively compared the performance of culture, direct fluorescent-antibody testing (DFA), and an in-house-developed PCR test targeting the repeated insertion sequence IS481 for the detection of Bordetella pertussis in nasopharyngeal swab specimens. We tested 319 consecutive paired specimens on which all three tests were performed. A total of 59 specimens were positive by one or more tests. Of these, 5 were positive by all three tests, 2 were positive by culture and PCR, 16 were positive by PCR and DFA, 28 were positive by PCR only, and 8 were positive by DFA only. Any specimen positive by culture was considered to be a true positive, as were specimens positive by both PCR and DFA. Specimens positive only by PCR or DFA were considered discrepant, and their status was resolved by review of patient histories. Patients with symptoms meeting the Centers for Disease Control and Prevention clinical case definition for pertussis and who had a specimen positive by PCR or DFA were considered to have true B. pertussis infections. Of the 28 patients positive by PCR only, 20 met the clinical case definition for pertussis, while 3 of the 8 patients positive by DFA only met the clinical case definition. After resolution of the status of discrepant specimens, the sensitivity, specificity, positive predictive value, and negative predictive value were 15.2, 100, 100, and 87.5%, respectively, for culture; 93.5, 97.1, 84.3, and 98.9%, respectively, for PCR; and 52.2, 98.2, 82.8, and 92.4%, respectively, for DFA. The actual positive predictive value of PCR was probably greater, as several PCR-positive patients who did not meet the clinical case definition had symptoms consistent with typical or atypical pertussis. PCR is a sensitive and specific method for the detection of B. pertussis.

AB - We prospectively compared the performance of culture, direct fluorescent-antibody testing (DFA), and an in-house-developed PCR test targeting the repeated insertion sequence IS481 for the detection of Bordetella pertussis in nasopharyngeal swab specimens. We tested 319 consecutive paired specimens on which all three tests were performed. A total of 59 specimens were positive by one or more tests. Of these, 5 were positive by all three tests, 2 were positive by culture and PCR, 16 were positive by PCR and DFA, 28 were positive by PCR only, and 8 were positive by DFA only. Any specimen positive by culture was considered to be a true positive, as were specimens positive by both PCR and DFA. Specimens positive only by PCR or DFA were considered discrepant, and their status was resolved by review of patient histories. Patients with symptoms meeting the Centers for Disease Control and Prevention clinical case definition for pertussis and who had a specimen positive by PCR or DFA were considered to have true B. pertussis infections. Of the 28 patients positive by PCR only, 20 met the clinical case definition for pertussis, while 3 of the 8 patients positive by DFA only met the clinical case definition. After resolution of the status of discrepant specimens, the sensitivity, specificity, positive predictive value, and negative predictive value were 15.2, 100, 100, and 87.5%, respectively, for culture; 93.5, 97.1, 84.3, and 98.9%, respectively, for PCR; and 52.2, 98.2, 82.8, and 92.4%, respectively, for DFA. The actual positive predictive value of PCR was probably greater, as several PCR-positive patients who did not meet the clinical case definition had symptoms consistent with typical or atypical pertussis. PCR is a sensitive and specific method for the detection of B. pertussis.

UR - http://www.scopus.com/inward/record.url?scp=0032789201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032789201&partnerID=8YFLogxK

M3 - Article

C2 - 10449467

AN - SCOPUS:0032789201

VL - 37

SP - 2872

EP - 2876

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 9

ER -